AI & Medicine 2025: Cutting-Edge Innovations, Generative AI, Virtual Reality, Telehealth, Biosensors

   +33 9 80 27 55 77

Dr. Wisit Cheungpasitporn, Guest of Honor in Paris for “Artificial Intelligence and Nephrology 2025”

Dr. Wisit Cheungpasitporn will be a featured speaker at the “Artificial Intelligence and Nephrology 2025” conference, taking place on November 20-21, 2025, at the Fondation Biermans-Lapôtre in Paris, France.

He will present a talk titled:
“How to Use Generative AI to Inform and Educate Patients,” where he will explore how AI tools can enhance patient education in nephrology.

Now in its third edition, this event will bring together international experts to discuss the latest innovations in AI applications for nephrology.

Biography

Dr. Wisit Cheungpasitporn is a world-renowned nephrologist and an innovative researcher pioneering the integration of artificial intelligence (AI) and machine learning (ML) into nephrology. His groundbreaking work is transforming the management of chronic kidney disease (CKD), hypertension, and acute kidney injury (AKI).

With a strong focus on personalized medicine, predictive analytics, and AI-driven clinical decision support, Dr. Cheungpasitporn is bridging the gap between technological advancements and real-world medical applications.

Pioneering Contributions to AI in Nephrology
 
1. AI and Machine Learning in Chronic Kidney Disease Management
In his landmark paper, “Revolutionizing Chronic Kidney Disease Management with Machine Learning and Artificial Intelligence” (J Clin Med, 2023), Dr. Cheungpasitporn explores how ML algorithms can improve CKD diagnosis, predict disease progression, and optimize treatment strategies. His work lays the foundation for AI-assisted nephrology.
 
2. AI in Sepsis-Associated Acute Kidney Injury (AKI)
Sepsis is a leading cause of AKI in critically ill patients. His study, “Artificial Intelligence and Machine Learning’s Role in Sepsis-Associated Acute Kidney Injury” (Kidney Res Clin Pract, 2024), demonstrates how AI models can identify high-risk patients, enabling early intervention and improved clinical outcomes.
 
3. ChatGPT and Large Language Models for Nephrologists
Dr. Cheungpasitporn has been instrumental in optimizing large language models (LLMs) like ChatGPT for nephrology applications. His publications include:
  • “How to Improve ChatGPT Performance for Nephrologists” (J Nephrol, 2024) – A guide for clinicians on maximizing AI-powered tools in nephrology practice.
  • “Integrating Retrieval-Augmented Generation with Large Language Models in Nephrology” (Medicina, 2024) – Exploring how AI can enhance medical literature retrieval and evidence-based practice.
4. AI in Hypertension and Kidney Transplantation
Hypertension and kidney transplantation require precise, real-time decision-making. His studies have demonstrated the transformative role of AI in these areas:
  • “Enhancing Clinical Decision-Making: Optimizing ChatGPT’s Performance in Hypertension Care” (J Clin Hypertens, 2024) – Showcasing how AI can aid in diagnosing and managing hypertension.
  • “Enhancing Kidney Transplant Care Through the Integration of Chatbots” (Healthcare, 2023) – Investigating AI-driven chatbot solutions for transplant patients and clinicians.
5. AI for Physician Support and Burnout Prevention
Medical documentation is a major source of physician burnout. His paper, “Should Artificial Intelligence Be Used for Physician Documentation to Reduce Burnout?” (Kidney360, 2024), discusses how AI can automate repetitive tasks, allowing nephrologists to focus more on patient care.
 
Impact and Future Directions

Dr. Cheungpasitporn’s pioneering work is leading the way toward a new era of AI-assisted nephrology, where predictive analytics, automation, and personalized medicine can significantly enhance patient outcomes.

His future research focuses on:

  • Advancing AI-driven precision nephrology
  • Developing AI tools for transplant medicine
  • Enhancing medical education with AI-powered chatbots
  • Improving AI-assisted clinical decision-making

As AI continues to evolve, Dr. Cheungpasitporn remains at the forefront, shaping the future of kidney care with innovative and intelligent medical solutions.

Article DOI